Champions Oncology (CSBR) Receivables - Other (2011 - 2026)

Champions Oncology's Receivables - Other history runs 16 years deep, the most recent figure standing at $6.2 million for Q1 2026.

• In Q1 2026, Receivables - Other rose 6.36% year-over-year to $6.2 million; the TTM figure through Jan 2026 stood at $6.2 million (up 6.36% YoY), while the FY2025 annual figure was $5.4 million, down 9.14% from the prior year.
• Receivables - Other was $6.2 million for Q1 2026 at Champions Oncology, down from $7.2 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $7.2 million in Q4 2025 to a low of $3.7 million in Q1 2023.
• Historically, Receivables - Other has averaged $5.1 million across 5 years, with a median of $5.0 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Receivables - Other fell 10.7% in 2023, then jumped 65.77% in 2024.
• A 5-year view of Receivables - Other shows it stood at $4.3 million in 2022, then fell by 7.28% to $4.0 million in 2023, then surged by 65.77% to $6.6 million in 2024, then grew by 8.09% to $7.2 million in 2025, then fell by 14.17% to $6.2 million in 2026.
• The last three Receivables - Other figures came in at $6.2 million (Q1 2026), $7.2 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.